Retinoblastoma treatment: Utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-d-glucose (2-FG), to target the chemoresistant hypoxic regions in LH BETAT AG retinal tumors

Yolanda Piña, Christina Decatur, Timothy G. Murray, Samuel K. Houston, Milena Lopez-Cavalcante, Eleut Hernandez, Magda Celdran, Nikesh Shah, William Feuer, Theodore Lampidis

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Retinoblastoma treatment: Utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-d-glucose (2-FG), to target the chemoresistant hypoxic regions in LH <sub>BETA</sub>T <sub>AG</sub> retinal tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences